Symphony was founded in 2014 and is headquartered in Palo Alto, US
Report incorrect company information
Key People/Management at Symphony
David Gurle
Founder & CEO
David Wilson
CFO
Derek Diperna
Head of Sales
Eran Barak
COO
Goutam Nadella
EVP, Client Solutions
Harry Patz
EVP Market Development
Report incorrect company information
Symphony Office Locations
Symphony has offices in Stockholm, Singapore, Hong Kong, Palo Alto and in 2 other locations
Palo Alto, US (HQ)
1117 S California Ave
New York, US
45d, 1 World Trade Center
Hong Kong, HK
5/F Champion Tower 3 Garden Road
Singapore, SG
8 Cross Street #28-01 PWC Building
Stockholm, SE
Grev Turegatan 3 (Trapphus D, vån 4)
London, GB
4 Lombard St
Report incorrect company information
Symphony Financials and Metrics
Summary Metrics
Founding Date | 2014 |
Total Funding | $296 m |
Latest funding size | $67 m |
Time since last funding | 2 months ago |
Investors | Societe Generale, Natixis, Bpifrance, Bank of America, BlackRock, Morgan Stanley, Citigroup, Nomura, Jefferies, HSBC, Goldman Sachs, JP Morgan, Merrill Lynch, Deutsche Bank, BNP Paribas, Maverick Capital, Wells Fargo & Company, Lakestar, UBS, Citadel, Credit Suisse, Merus Capital, Barclays PLC, JPMorgan Investment, Google, HSBC Bank, CLSA, BNY Mellon, Citibank |
Symphony's latest funding round in April 2018 was reported to be $67 m. In total, Symphony has raised $296 m. Symphony's latest valuation is reported to be $1 b.
Symphony Financials
Market valuation | 1 b |
- Source: Techcrunch
Symphony Operating Metrics
Symphony's Users was reported to be 325 k in Y, 2016.
| Y, 2016 | May, 2017 | |
|---|---|---|
Paying Customers | 200 k | |
Users | 325 k |
Report incorrect company information
Symphony Online and Social Media Presence
Report incorrect company information
Symphony News and Updates
June 01, 2018
Ahead of ASCO, BMS' Opdivo leads Merck's Keytruda in U.S. sales—but not for long, analyst predicts
With all eyes on cancer treatments this weekend at the American Society of Clinical Oncology annual meeting—in particular, immuno-oncology treatments—Bristol Myers Squibb’s Opdivo still leads the pack in terms of U.S. sales. But analysts don’t expect that lead to last.
May 28, 2018
Swedish symphony turns homophobic hate mail into beautiful music
There's no better troll than a classical music orchestra troll.
Last month, the Helsingborg Symphony Orchestra in Sweden received a piece of homophobic hate mail after the orchestra performed music by LGBTQ composers. Instead of tearing the hate mail up, however, the orchestra decided to turn the …
Report incorrect company information